Compare CHYM & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CHYM | BAX |
|---|---|---|
| Founded | 2012 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 13.4B |
| IPO Year | 2025 | 1994 |
| Metric | CHYM | BAX |
|---|---|---|
| Price | $32.41 | $25.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 23 | 15 |
| Target Price | ★ $42.38 | $27.25 |
| AVG Volume (30 Days) | 4.7M | ★ 6.8M |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 0.16% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.31 | ★ 0.78 |
| Revenue | $2,186,770,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $28.06 | $4.27 |
| Revenue Next Year | $23.18 | $2.01 |
| P/E Ratio | $106.23 | ★ $33.04 |
| Revenue Growth | ★ 30.69 | 5.72 |
| 52 Week Low | $15.88 | $15.73 |
| 52 Week High | $35.55 | $30.00 |
| Indicator | CHYM | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 57.45 | 55.56 |
| Support Level | $30.95 | $25.75 |
| Resistance Level | $33.41 | $25.99 |
| Average True Range (ATR) | 1.37 | 0.98 |
| MACD | 0.27 | 0.01 |
| Stochastic Oscillator | 66.43 | 75.49 |
Chime Financial Inc is a financial technology company that provides digital banking services through its proprietary technology platform in partnership with third-party banks. The company offers various financial products and services designed to meet members' financial needs, including spending accounts, liquidity solutions, credit-building tools, savings products, and community-focused financial services.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.